1-4 of 4
Gregory Pastores
Close
Sort by
Journal Articles

Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years

M. Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory Pastores, M.D., Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D.
Journal: Blood
Blood (2011) 118 (21): 1104.
https://doi.org/10.1182/blood.V118.21.1104.1104
Published: 2011
Journal Articles

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Elena Lukina, Judith Peterschmitt, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory Pastores, Elsa Avila Arreguin, Hanna Rosenbaum, Mici Phillips, Mathilde Kaper, Arshadul Haque, Ana Cristina Puga
Journal: Blood
Blood (2010) 116 (21): 3791.
https://doi.org/10.1182/blood.V116.21.3791.3791
Published: 2010
Journal Articles

Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.

Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Patricia Watman, MD, Elsa Avila Arreguin, MD, Maryam Banikazemi, MD, Gregory Pastores, MD, Marcelo Iastrebner, MD, Marta Dragosky, MD, Hanna Rosenbaum, MD, Mici Phillips, MD, Mathilde Kaper, Tejdip Singh, MD, Ana Cristina Puga, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1349.
https://doi.org/10.1182/blood.V114.22.1349.1349
Published: 2009
Journal Articles

Effect of Enzyme Replacement Therapy on Bone Mineral Density in Type 1 Gaucher Disease.

Richard Wenstrup, MD, Katherine Kacena, PhD, Paige Kaplan, MD, Gregory Pastores, MD, Ainu Prakash-Cheng, PhD, MD, Ari Zimran, MD, Thomas Hangartner, PhD
Journal: Blood
Blood (2005) 106 (11): 3895.
https://doi.org/10.1182/blood.V106.11.3895.3895
Published: 2005